Recent studies showed that miR-338-3p acted as a tumor suppressor in GC by targeting zinc finger E-boxbinding protein 2, ADAM metallopeptidase domain 17, and P-Rex2a30, 31, 49. This evidence concerns the gene ADAM17 and neoplasm.